Evidence map›Paper›PMID 36271928›Full record

ArticleEuropean archives of psychiatry and clinical neuroscience2023

Examining the synergistic effects of a cognitive control video game and a home-based, self-administered non-invasive brain stimulation on alleviating depression: the DiSCoVeR trial protocol.

Esther Dechantsreiter, Frank Padberg, Alon Morash, Ulrike Kumpf, Arthur Nguyen, Zeno Menestrina, Fabienne Windel, Gerrit Burkhardt, Stephan Goerigk, Takuya Morishita and 19 more

Registry-linked trialOpen access · hybridAbstract readClinical Trial Protocol
In one paragraph

Article in European archives of psychiatry and clinical neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04953208 (The DiSCoVeR Project), which is not on this map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04953208 naunknown statusnot on this map

The DiSCoVeR Project: Examining the Synergistic Effects of a Cognitive Control Videogame and a Self-administered Non-invasive Brain Stimulation on Alleviating Depression

TypeinterventionalSponsorMor NahumRan2021 to 2024Enrolled114ConditionsMajor Depressive DisorderArmsactive tDCS, sham tDCS, cognitive and emotional control video game, sham video game
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Trial
  2. Major depressive disorder-alcohol use disorder comorbidity: diagnosis, mechanisms and treatment.European archives of psychiatry and clinical neuroscience · 2026
    Review
  3. Article
  4. Remote group intervention for adults with cancer-related cognitive impairment: a feasibility study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 11 institutions in 4 countries.

Esther Dechantsreiter *Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-University Munich, Nussbaumstr. 7, 80336, Munich, Germany.
Frank Padberg *Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-University Munich, Nussbaumstr. 7, 80336, Munich, Germany. padberg@med.uni-muenchen.de.
Alon MorashHadassah Medical Center, Jerusalem, Israel.
Ulrike KumpfDepartment of Psychiatry and Psychotherapy, Ludwig-Maximilians-University Munich, Nussbaumstr. 7, 80336, Munich, Germany.
Arthur NguyenFaculty of Psychology and Educational Sciences, University of Geneva, and Campus Biotech, Geneva, Switzerland.
Zeno MenestrinaFaculty of Psychology and Educational Sciences, University of Geneva, and Campus Biotech, Geneva, Switzerland.
Fabienne WindelDefitech Chair of Clinical Neuroengineering, Neuro-X Institute (INX) and Brain Mind Institute (BMI), Ecole Polytechnique Fédérale de Lausanne (EPFL), Geneva, Switzerland.
Gerrit BurkhardtDepartment of Psychiatry and Psychotherapy, Ludwig-Maximilians-University Munich, Nussbaumstr. 7, 80336, Munich, Germany.
Stephan GoerigkDepartment of Psychiatry and Psychotherapy, Ludwig-Maximilians-University Munich, Nussbaumstr. 7, 80336, Munich, Germany.
Takuya MorishitaDefitech Chair of Clinical Neuroengineering, Neuro-X Institute (INX) and Brain Mind Institute (BMI), Ecole Polytechnique Fédérale de Lausanne (EPFL), Geneva, Switzerland.
Aldo SoldiniDepartment of Psychiatry and Psychotherapy, Ludwig-Maximilians-University Munich, Nussbaumstr. 7, 80336, Munich, Germany.
Shira AhissarSchool of Occupational Therapy, Faculty of Medicine, The Hebrew University, Jerusalem, Israel.
Tamar CohenSchool of Occupational Therapy, Faculty of Medicine, The Hebrew University, Jerusalem, Israel.
Angela PasqualottoFaculty of Psychology and Educational Sciences, University of Geneva, and Campus Biotech, Geneva, Switzerland.
Linda RubeneDepartment of Psychiatry and Narcology, Riga Stradins University, Riga, Latvia.
Liene KonosonokaDepartment of Psychiatry and Narcology, Riga Stradins University, Riga, Latvia.
Daniel KeeserDepartment of Psychiatry and Psychotherapy, Ludwig-Maximilians-University Munich, Nussbaumstr. 7, 80336, Munich, Germany.
Peter ZillDepartment of Psychiatry and Psychotherapy, Ludwig-Maximilians-University Munich, Nussbaumstr. 7, 80336, Munich, Germany.
Razan AssiSchool of Occupational Therapy, Faculty of Medicine, The Hebrew University, Jerusalem, Israel.
Rémy GardierSignal Processing Laboratory 5 (LTS5), Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
Roser ViñalsSignal Processing Laboratory 5 (LTS5), Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
Jean-Philippe ThiranSignal Processing Laboratory 5 (LTS5), Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
Ronen SegmanHadassah Medical Center, Jerusalem, Israel.
Yuval BenjaminiDepartment of Statistics and Data Science, Faculty of Social Sciences, The Hebrew University, Jerusalem, Israel.
Omer BonneHadassah Medical Center, Jerusalem, Israel.
Friedhelm Christoph HummelDefitech Chair of Clinical Neuroengineering, Neuro-X Institute (INX) and Brain Mind Institute (BMI), Ecole Polytechnique Fédérale de Lausanne (EPFL), Geneva, Switzerland.
Daphne BavelierFaculty of Psychology and Educational Sciences, University of Geneva, and Campus Biotech, Geneva, Switzerland.
Elmars RancansDepartment of Psychiatry and Narcology, Riga Stradins University, Riga, Latvia.
Mor NahumSchool of Occupational Therapy, Faculty of Medicine, The Hebrew University, Jerusalem, Israel.
Ludwig-Maximilians-Universität München · DEHebrew University of Jerusalem · ILUniversity of Geneva · CHClinique Romande de Réadaptation · CHHadassah Medical Center · ILÉcole Polytechnique Fédérale de Lausanne · CHRiga Stradiņš University · LVCentre d'Imagerie BioMedicale · CHHologic (Germany) · DELMU Klinikum · DERiga Technical College · LV

Funding

Bundesministerium für Bildung und Forschung 01EW1903
6 · The paper itself

Abstract

Enhanced behavioral interventions are gaining increasing interest as innovative treatment strategies for major depressive disorder (MDD). In this study protocol, we propose to examine the synergistic effects of a self-administered home-treatment, encompassing transcranial direct current stimulation (tDCS) along with a video game based training of attentional control. The study is designed as a two-arm, double-blind, randomized and placebo-controlled multi-center trial (ClinicalTrials.gov: NCT04953208). At three study sites (Israel, Latvia, and Germany), 114 patients with a primary diagnosis of MDD undergo 6 weeks of intervention (30 × 30 min sessions). Patients assigned to the intervention group receive active tDCS (anode F3 and cathode F4; 2 mA intensity) and an action-like video game, while those assigned to the control group receive sham tDCS along with a control video game. An electrode-positioning algorithm is used to standardize tDCS electrode positioning. Participants perform their designated treatment at the clinical center (sessions 1-5) and continue treatment at home under remote supervision (sessions 6-30). The endpoints are feasibility (primary) and safety, treatment efficacy (secondary, i.e., change of Montgomery-Åsberg Depression Rating Scale (MADRS) scores at week six from baseline, clinical response and remission, measures of social, occupational, and psychological functioning, quality of life, and cognitive control (tertiary). Demonstrating the feasibility, safety, and efficacy of this novel combined intervention could expand the range of available treatments for MDD to neuromodulation enhanced interventions providing cost-effective, easily accessible, and low-risk treatment options.ClinicalTrials.gov: NCT04953208.

Indexed as

Major Depressive DisorderTranscranial Direct Current StimulationBrainCognitionDepressionDouble-Blind MethodHumansMulticenter Studies as TopicQuality of LifeRandomized Controlled Trials as TopicTreatment OutcomeCognitive controlFeasibilityHome-treatmentMajor depressive disorderTranscranial direct current stimulation (tDCS)Video game

Identifiers

PMID36271928
PMCPMC9589526
OpenAlexW4307090171

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.